Sequence heterogeneity of the echinococcal antigen B.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMID 8078520)

Published in Mol Biochem Parasitol on March 01, 1994

Authors

P Frosch1, M Hartmann, F Mühlschlegel, M Frosch

Author Affiliations

1: Institut für Medizinische Mikrobiologie, Medizinische Hochschule Hannover, Germany.

Articles citing this

Concepts in immunology and diagnosis of hydatid disease. Clin Microbiol Rev (2003) 2.77

Improved immunodiagnosis of cystic hydatid disease by using a synthetic peptide with higher diagnostic value than that of its parent protein, Echinococcus granulosus antigen B. J Clin Microbiol (2000) 1.26

Usefulness of hydatid cyst fluid of Echinococcus granulosus developed in mice with secondary infection for serodiagnosis of cystic Echinococcosis in humans. Clin Diagn Lab Immunol (2002) 1.13

Molecular cloning, expression, and serological evaluation of an 8-kilodalton subunit of antigen B from Echinococcus multilocularis. J Clin Microbiol (2004) 1.13

Host-parasite relationship in cystic echinococcosis: an evolving story. Clin Dev Immunol (2011) 1.05

The Echinococcus granulosus antigen B gene family comprises at least 10 unique genes in five subclasses which are differentially expressed. PLoS Negl Trop Dis (2010) 1.01

Echinococcus granulosus antigen B structure: subunit composition and oligomeric states. PLoS Negl Trop Dis (2012) 0.92

Serological Evaluation of EgAgB16 kDa, a Recombinant Antigen from Echinococcus granulosus for Diagnosis of Human Hydatidosis. Iran J Parasitol (2010) 0.91

Genetic variability of antigen B among Echinococcus granulosus Egyptian isolates. Korean J Parasitol (2009) 0.89

Echinococcus granulosus strain typing in Bulgaria: the G1 genotype is predominant in intermediate and definitive wild hosts. Parasitol Res (2004) 0.84

Echinococcus P29 antigen: molecular characterization and implication on post-surgery follow-up of CE patients infected with different species of the Echinococcus granulosus complex. PLoS One (2014) 0.82

Lipid-free antigen B subunits from echinococcus granulosus: oligomerization, ligand binding, and membrane interaction properties. PLoS Negl Trop Dis (2015) 0.77

Echinococcus granulosus Antigen B binds to monocytes and macrophages modulating cell response to inflammation. Parasit Vectors (2016) 0.76

Lipid binding proteins from parasitic platyhelminthes. Front Physiol (2012) 0.75

Articles by these authors

30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet (2006) 7.88

Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res (2001) 3.89

Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet (1996) 3.78

CT and diffusion-weighted MR imaging in randomized order: diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke. Stroke (2002) 3.74

Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element. EMBO J (1996) 2.80

Non-culture diagnosis and serogroup determination of meningococcal B and C infection by a sialyltransferase (siaD) PCR ELISA. Epidemiol Infect (1997) 2.67

European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol (2004) 2.65

Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem (1997) 2.57

NZB mouse system for production of monoclonal antibodies to weak bacterial antigens: isolation of an IgG antibody to the polysaccharide capsules of Escherichia coli K1 and group B meningococci. Proc Natl Acad Sci U S A (1985) 2.49

Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease. Mol Microbiol (1996) 2.30

Non-O157:H7 pathogenic Shiga toxin-producing Escherichia coli: phenotypic and genetic profiling of virulence traits and evidence for clonality. J Infect Dis (1999) 2.04

Endovenous laser ablation with and without high ligation compared with high ligation and stripping in the treatment of great saphenous varicose veins: initial results of a multicentre randomized controlled trial. Phlebology (2012) 2.03

Intuitive hypertext-based molecular identification of micro-organisms. Lancet (1999) 2.01

The large plasmids of Shiga-toxin-producing Escherichia coli (STEC) are highly variable genetic elements. Microbiology (1999) 1.97

Independent effects of IgG and complement upon human polymorphonuclear leukocyte function. J Immunol (1976) 1.97

"False-positive" anti-neutrophil cytoplasmic antibodies in HIV infection. Lancet (1990) 1.94

Detection of Mycoplasma pneumoniae by polymerase chain reaction and nonradioactive hybridization in microtiter plates. J Clin Microbiol (1993) 1.91

Contaminations occurring in fungal PCR assays. J Clin Microbiol (1999) 1.86

Contribution of genes from the capsule gene complex (cps) to lipooligosaccharide biosynthesis and serum resistance in Neisseria meningitidis. Mol Microbiol (1994) 1.82

Necessity of molecular techniques to distinguish between Neisseria meningitidis strains isolated from patients with meningococcal disease and from their healthy contacts. J Clin Microbiol (1998) 1.80

Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients. Biol Chem Hoppe Seyler (1989) 1.76

Mechanisms of neisserial serum resistance. Mol Microbiol (1999) 1.71

Comparison of CT with diffusion-weighted MRI in patients with hyperacute stroke. Neuroradiology (2001) 1.68

Molecular divergence of the sia locus in different serogroups of Neisseria meningitidis expressing polysialic acid capsules. Mol Gen Genet (1997) 1.68

Diagnostics of neisseriaceae and moraxellaceae by ribosomal DNA sequencing: ribosomal differentiation of medical microorganisms. J Clin Microbiol (2001) 1.66

Molecular analysis of the biosynthesis pathway of the alpha-2,8 polysialic acid capsule by Neisseria meningitidis serogroup B. Mol Microbiol (1994) 1.66

Escherichia coli O157:H7 and O157:H(-) strains that do not produce Shiga toxin: phenotypic and genetic characterization of isolates associated with diarrhea and hemolytic-uremic syndrome. J Clin Microbiol (1999) 1.65

Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis. Infect Immun (1997) 1.65

Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Rheumatol Int (2011) 1.64

siaD PCR ELISA for confirmation and identification of serogroup Y and W135 meningococcal infections. FEMS Microbiol Lett (1998) 1.61

Acute disseminated encephalomyelitis following vaccination against human papilloma virus. Neurology (2009) 1.61

Active syphilis in HIV infection: a multicentre retrospective survey. The German AIDS Study Group (GASG). Genitourin Med (1996) 1.58

Autoantibodies in psoriasis as predictors for loss of response and anti-infliximab antibody induction. Br J Dermatol (2011) 1.51

Clinical and immunologic follow-up study of patients with neurocysticercosis after treatment with praziquantel. Neurology (1995) 1.49

Sialic acids of both the capsule and the sialylated lipooligosaccharide of Neisseria meningitis serogroup B are prerequisites for virulence of meningococci in the infant rat. Med Microbiol Immunol (1996) 1.46

Influence of intraventricular fibrinolytic therapy with rt-PA on the long-term outcome of treated patients with spontaneous basal ganglia hemorrhage: a case-control study. Eur J Neurol (2008) 1.45

Does acute occlusion of the carotid T invariably have a poor outcome? Neurology (2004) 1.44

Dominant active alleles of RIM101 (PRR2) bypass the pH restriction on filamentation of Candida albicans. Mol Cell Biol (2000) 1.43

The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis. Mol Immunol (2000) 1.43

Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes. Vaccine (2001) 1.42

Persistent hypoglossal artery: MRI, MRA and digital subtraction angiography. Neuroradiology (2001) 1.42

Post-transformational rearrangement of an in vitro reconstructed group-A streptococcal erythromycin resistance plasmid. Plasmid (1979) 1.42

Molecular basis for distinction of the ET-15 clone within the ET-37 complex of Neisseria meningitidis. J Clin Microbiol (2000) 1.41

Glutaryl-coenzyme A dehydrogenase deficiency: a distinct encephalopathy. Pediatrics (1991) 1.41

Staphylococcus aureus in urine and false-positive immunoassay for Chlamydia. Lancet (1992) 1.39

["Second opinion centers". Approach for improving the quality of treatment for testicular tumors]. Urologe A (2006) 1.39

[68-year-old female patient with dyspnea and hypokalemic hypertension]. Internist (Berl) (2007) 1.38

Prevention of paraplegia during aortic operations. Ann Thorac Surg (1990) 1.38

Cloning and characterisation of an immunodominant major surface antigen of Echinococcus multilocularis. Mol Biochem Parasitol (1991) 1.38

Rapid serogroup switching in Neisseria meningitidis. N Engl J Med (2000) 1.38

The role of galE in the biosynthesis and function of gonococcal lipopolysaccharide. Mol Microbiol (1993) 1.37

An epidemiologic survey of human alveolar echinococcosis in southwestern Germany. Römerstein Study Group. Am J Trop Med Hyg (1999) 1.36

Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors. Neurology (2006) 1.36

Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B. J Infect Dis (2001) 1.35

New tumor-inhibiting metal complexes. Chemistry and antitumor properties. Met Based Drugs (1994) 1.33

Rapid PCR test for discriminating between Candida albicans and Candida dubliniensis isolates using primers derived from the pH-regulated PHR1 and PHR2 genes of C. albicans. J Clin Microbiol (1999) 1.31

Neospora caninum and Waddlia chondrophila strain 2032/99 in a septic stillborn calf. Vet Microbiol (2002) 1.31

Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors. Cancer Res (1991) 1.28

Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability. Circ Res (2000) 1.27

Differential distribution of novel restriction-modification systems in clonal lineages of Neisseria meningitidis. J Bacteriol (2000) 1.26

Secretory expression in Escherichia coli and Bacillus subtilis of human interferon alpha genes directed by staphylokinase signals. Mol Gen Genet (1989) 1.26

Hepatotoxicity in patients prescribed efavirenz or nevirapine. Eur J Med Res (2008) 1.26

Molecular characterization of eukaryotic polysialyltransferase-1. Nature (1995) 1.25

Role of lipopolysaccharide sialylation in serum resistance of serogroup B and C meningococcal disease isolates. Infect Immun (1999) 1.24

S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14. J Biol Chem (1999) 1.24

Evidence for the extended helical nature of polysaccharide epitopes. The 2.8 A resolution structure and thermodynamics of ligand binding of an antigen binding fragment specific for alpha-(2-->8)-polysialic acid. Biochemistry (1995) 1.24

Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann Neurol (1998) 1.23

Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane. J Rheumatol (1999) 1.22

Anti-endothelial serum antibodies in a patient with Susac's syndrome. J Neurol Sci (2009) 1.21

Site-specific insertion of IS1301 and distribution in Neisseria meningitidis strains. J Bacteriol (1996) 1.21

Physical and conformational properties of staphylokinase in solution. Biochim Biophys Acta (1993) 1.21

Genetic diversity of Neisseria lactamica strains from epidemiologically defined carriers. J Clin Microbiol (2001) 1.21

Oral naloxone reverses opioid-associated constipation. Pain (2000) 1.20

Lack of pharmacokinetic interaction as an equivalence problem. Int J Clin Pharmacol Ther Toxicol (1991) 1.19

Genetic isolation of meningococci of the electrophoretic type 37 complex. J Bacteriol (2001) 1.19

Prognostic factors in seminomas with special respect to HCG: results of a prospective multicenter study. Seminoma Study Group. Eur Urol (1999) 1.19

Stent placement for flow restoration in acute ischemic stroke: a single-center experience with the Solitaire stent system. AJNR Am J Neuroradiol (2011) 1.18

Diagnosis of Echinococcus multilocularis infection by reverse-transcription polymerase chain reaction. Gastroenterology (1995) 1.18

Neisseria meningitidis producing the Opc adhesin binds epithelial cell proteoglycan receptors. Mol Microbiol (1998) 1.18

Systemic infection of an immunocompromised patient with Methylobacterium zatmanii. J Clin Microbiol (1999) 1.17

Genetic rearrangement of FOXP1 is predominantly detected in a subset of diffuse large B-cell lymphomas with extranodal presentation. Leukemia (2006) 1.17

The influence of capsulation and lipooligosaccharide structure on neutrophil adhesion molecule expression and endothelial injury by Neisseria meningitidis. J Infect Dis (1996) 1.16

Cloning and functional characterization of a 30 kb gene locus required for lipopolysaccharide biosynthesis in Legionella pneumophila. Int J Med Microbiol (2000) 1.16

Functional characterization of an isogenic meningococcal alpha-2,3-sialyltransferase mutant: the role of lipooligosaccharide sialylation for serum resistance in serogroup B meningococci. Med Microbiol Immunol (1997) 1.15

The breast cancer-associated MUC1 gene generates both a receptor and its cognate binding protein. Cancer Res (1999) 1.14

Molecular cloning and functional expression of bacteriophage PK1E-encoded endoneuraminidase Endo NE. Mol Microbiol (1995) 1.13

Activation of complement by mannose-binding lectin on isogenic mutants of Neisseria meningitidis serogroup B. J Immunol (1998) 1.13

Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with Chlamydia pneumoniae. Infect Immun (2000) 1.12

Cerebrovascular manifestations of Takayasu arteritis in Europe. Rheumatology (Oxford) (2005) 1.11

Cloning and expression of a cDNA encoding an elongation factor 1beta/delta protein from Echinococcus granulosus with immunogenic activity. Parasite Immunol (1999) 1.11

Genetic study of plasmid-associated zonal resistance to lincomycin in Streptococcus pyogenes. Antimicrob Agents Chemother (1981) 1.11

Endovascular therapy of arteriovenous fistulae with electrolytically detachable coils. Neuroradiology (1999) 1.10

Clinical aspects and pathogenesis of Candida infection. Trends Microbiol (1998) 1.10

Chromosomal insertion and excision of a 30 kb unstable genetic element is responsible for phase variation of lipopolysaccharide and other virulence determinants in Legionella pneumophila. Mol Microbiol (2001) 1.09

Serological diagnosis of human cysticercosis by use of recombinant antigens from Taenia solium cysticerci. Clin Diagn Lab Immunol (1999) 1.09

Disseminated Penicillium marneffei infection in an HIV-positive female from Thailand in Germany. Mycoses (1999) 1.08

Specificity of antibodies directed against Env protein of human endogenous retroviruses in patients with germ cell tumors. Cancer Res (1996) 1.08

Use of recombinant mitogillin for improved serodiagnosis of Aspergillus fumigatus-associated diseases. J Clin Microbiol (2001) 1.07

The central, surface-exposed region of the flagellar hook protein FlgE of Campylobacter jejuni shows hypervariability among strains. J Bacteriol (1998) 1.07